Name: Acrivon Therapeutics, Inc. (ACRV) Cash Flow Statement
Creator: FinSpry

Acrivon Therapeutics Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for Acrivon Therapeutics, Inc. (ACRV) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Operating Activities
Net Income	-80.56	-60.39	-31.17	-16.24	-5.31
Depreciation & Amortization	1.01	0.54	0.36	0.04	0.01
Stock Based Compensation	14.29	11.62	2.19	0.50	0.00
Change in Working Capital	2.44	8.14	-1.53	0.33	0.32
Change in Accounts Payable	-3.59	3.61	-0.25	0.80	0.08
Change in Other Working Capital	0.93	0.78	-1.29	-0.47	0.24
Other Operating Activities	0.93	0.78	0.73	1.40	2.17
Net Cash from Operating Activities	-65.67	-42.64	-30.12	-13.98	-2.80
Investing Activities
Capital Expenditures	-2.77	-1.29	-2.17	-0.24	-0.02
Purchases of Investments	-202.93	-56.53	-139.51	0.00	0.00
Sales/Maturities of Investments	153.92	108.53	-139.51	0.00	0.00
Net Cash from Investing Activities	-51.77	50.72	-141.68	-0.24	-0.02
Financing Activities
Common Stock Issued	70.00	0.78	104.48	0.00	0.00
Common Stock Repurchased	-2.52	-1.30	0.00	0.00	0.00
Other Financing Activities	-9.06	-2.33	-2.77	0.00	0.00
Net Cash from Financing Activities	121.03	-1.55	101.71	112.22	2.89
Summary
Net Change in Cash	3.59	6.52	-70.08	98.00	0.07
Cash at Beginning of Period	36.43	29.91	99.99	1.99	0.00
Cash at End of Period	40.02	36.43	29.91	99.99	0.00
Free Cash Flow	-68.44	-43.93	-32.28	-14.22	-2.82